New Clinical study: Pleased to announce three new clinical trials to test new treatments for dry eyes.
New Clinical study: Re the efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension study.
Click to see it.
Our Eye Ball ’17 will be held October 12th at the Hilton St. Louis Frontenac. The Eye Ball not only helps us raise needed funds to support all of our programs, but it is also a great evening including...
Doctor’s Seminar: BromSiteTM – First NSAID, FDA-approved for prevention of ocular pain in patients undergoing cataract surgery featuring Dr. Jay Pepose, Medical Director, Pepose Vision Institute
We’re pleased to welcome three more Board Members: Donna Hibler, Captain Eichel Johnson and Dr. Elizabeth Schmitz. Each brings valuable experience and passion and will be great additions to our strong Board.
New Doctor’s Seminar : Innovations in surgical vision correction and pharmaceutical advances sparking FDA Trials
Click here to see it online.
Doctor’s Seminar : Pathophysiology, Diagnosis, and Latest Advancements in the Management of Keratoconus: Collagen Cross-Linking and Intacs, featuring Dr. Mujtaba A. Qazi, Director, Clinical Studies, Pepose Vision Institute
We are pleased to announce our clinical research study designed to evaluate the safety and efficacy of iontophoresis treatment with dexamethasone phosphate ophthalmic solution in patients who have non-infectious anterior segment uveitis. Iontophoresis is an investigational drug delivery system which...